Cat.#: ACPP-1549
| Despition | VEGF C Human Recombinant |
| SIZE | 2 µg |
| Purity | > 90.0% (SDS-PAGE) |
| Form | Sterile Filtered White lyophilized (freeze-dried) powder. |
| Storage | Lyophilized was stored and desiccated below -18°C. |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1202 | Pin1 Blocking Peptide (AC1202) | 250 µg | inquiry |
| ACPP-1479 | Human TIMP1 Protein, HEK (AC1479) | 2 µg | inquiry |
| ACPP-1295 | Human ASPH Protein (AC1295) | 5 µg | inquiry |
| ACPP-1547 | Human CA14 Protein (AC1547) | 5 µg | inquiry |
| ACPP-1489 | Human PSPN Protein (AC1489) | 5 µg | inquiry |
| ACPP-1377 | Human KCNMB3 Protein (AC1377) | 5 µg | inquiry |
| ACPP-1024 | Recombinant Human FGF2 Protein (mutated Q65I + C96S + N111G). (AC1024) | 50 µg | inquiry |
| ACPP-1107 | Recombinant Human Syndecan-1 Protein (Fc Chimera 6xHis Tag) (AC1107) | 50 µg | inquiry |
| ACPP-1681 | Human CALN1 Protein (AC1681) | 1 µg | inquiry |
| ACPP-1558 | Human ALK/P80 Protein (AC1558) | 2 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.